Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells

导出原文传递

翻译打印收藏纠错

作者： Sapra,P. ^[1] ; Damelin,M. ^[2] ; DiJoseph,J. ^[3] ; Marquette,K. ^[4] ; Geles,K.G. ^[5] ; Golas,J. ; Dougher,M. ; Narayanan,B. ; Giannakou,A. ; Khandke,K. ; Dushin,R. ; Ernstoff,E. ; Lucas,J. ; Leal,M. ; Hu,G. ; O'Donnell,C.J. ; Tchistiakova,L. ; Abraham,R.T. ; Gerber,H.-P.

作者单位： Oncology Research Unit, Pfizer Inc., 401 N Middletown Road, Pearl River, NY 10965, United States ^[1] Global BioTherapeutic Technologies, Pfizer Inc., Cambridge, MA, United States ^[2] Worldwide Medicinal Chemistry, Pfizer Inc., Groton, CT, United States ^[3] Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Pearl River, NY, United States ^[4] Drug Safety Research and Development, Pfizer Inc., Pearl River, NY, United States ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular cancer therapeutics

2013年12卷1期

38-47页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

检索历史清除